» Articles » PMID: 33179624

Gastrointestinal Lymphoproliferative Lesions: a Practical Diagnostic Approach

Overview
Journal Pathologica
Specialty Pathology
Date 2020 Nov 12
PMID 33179624
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The gastrointestinal tract (GI) is the primary site of lymphoproliferative lesions, spanning from reactive lymphoid hyperplasia to overt lymphoma. The diagnosis of these diseases is challenging and an integrated approach based on clinical, morphological, immunohistochemical and molecular data is needed. To reach to confident conclusions, a stepwise approach is highly recommended. Histological evaluation should first assess the benign neoplastic nature of a given lymphoid infiltrate. Morphological and phenotypic analyses should then be applied to get to a definite diagnosis. This review addresses the key histological features and diagnostic workup of the most common GI non-Hodgkin lymphomas (NHLs). Differential diagnoses and possible pitfalls are discussed by considering distinct groups of lesions ( small to medium B-cell NHLs; medium to large B-cell NHLs; T-cell NHLs; and mimickers of Hodgkin lymphoma). The key clinical and epidemiological features of each entity are also described.

Citing Articles

Non-neoplastic B-cell predominant lymphoid proliferations at the organs exposed to external environment mimicking lymphoma: A potential diagnostic pitfall.

Fan Y, Thong B, Binshen O, Shen X, Yi H, Wang C Int J Immunopathol Pharmacol. 2024; 38:3946320241264369.

PMID: 38886178 PMC: 11185012. DOI: 10.1177/03946320241264369.


Intestinal T-cell lymphoma not otherwise specified: a case report and literature review.

Laabidi S, Hamouga R, Bouslama S, Sellami R, Shimi S, Labidi A Future Sci OA. 2024; 10(1):FSO942.

PMID: 38817379 PMC: 11137769. DOI: 10.2144/fsoa-2023-0119.


Imaging Manifestations of Intrahepatic Reactive Lymphoid Hyperplasia: A Case Report and Literature Review.

Zhang B, Zou M, Lu Z, Mao H, Huang Y, Liu F Front Oncol. 2021; 11:694934.

PMID: 34956855 PMC: 8695756. DOI: 10.3389/fonc.2021.694934.


Synchronous primary gastric triple-hit high-grade B-cell lymphoma and gastric adenocarcinoma: endoscopic and pathological findings.

Covelli C, Parente P, Trombetta D, Graziano P BMJ Case Rep. 2021; 14(7).

PMID: 34285036 PMC: 8292813. DOI: 10.1136/bcr-2021-244643.

References
1.
Li L, Li Y, Que X, Gao X, Gao Q, Yu M . Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis. Sci Rep. 2018; 8(1):6267. PMC: 5908914. DOI: 10.1038/s41598-018-24631-5. View

2.
Pizzi M, Agostinelli C, Righi S, Gazzola A, Mannu C, Galuppini F . Aberrant expression of CD10 and BCL6 in mantle cell lymphoma. Histopathology. 2017; 71(5):769-777. DOI: 10.1111/his.13286. View

3.
Delabie J, Holte H, Vose J, Ullrich F, Jaffe E, Savage K . Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood. 2011; 118(1):148-55. DOI: 10.1182/blood-2011-02-335216. View

4.
Choi W, Weisenburger D, Greiner T, Piris M, Banham A, Delabie J . A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009; 15(17):5494-502. PMC: 7289055. DOI: 10.1158/1078-0432.CCR-09-0113. View

5.
Marks E, Shi Y . Duodenal-Type Follicular Lymphoma: A Clinicopathologic Review. Arch Pathol Lab Med. 2018; 142(4):542-547. DOI: 10.5858/arpa.2016-0519-RS. View